Takeda Pharmaceutical
TAK
#408
Rank
S$77.21 B
Marketcap
S$24.18
Share price
0.21%
Change (1 day)
28.23%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): -S$0.15 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are S$29.54 Billion. In 2025 the company made an earning of S$4.25 Billion, an increase over its 2024 earnings that were of S$2.85 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.15 Billion-103.32%
2025 S$4.25 B49.03%
2024 S$2.85 B-2.41%
2023 S$2.92 B-28.14%
2022 S$4.07 B-40.9%
2021 S$6.88 B78.24%
2020 S$3.86 B246.1%
2019 S$1.11 B-48.79%
2018 S$2.18 B-23.64%
2017 S$2.85 B21.7%
2016 S$2.34 B-253.01%
2015 -S$1.54 Billion-159.65%
2014 S$2.57 B13%
2013 S$2.27 B2.46%
2012 S$2.21 B-57.05%
2011 S$5.16 B-10.49%
2010 S$5.77 B-3.99%
2009 S$6.01 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.52 B-21,333.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$19.85 B-12,675.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$8.83 B-5,695.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$13.15 B-8,434.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.15 B-5,901.19%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$9.83 B-6,330.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$10.09 B-6,491.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-S$1.02 Billion 540.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
S$0.64 B-507.73%๐Ÿ‡ฎ๐Ÿ‡ณ India